Latest news
Positive results from the mid-stage trial of the hot flash treatment drug ABCL635, AbCellera Biologics (ABCL.US) surges in response - BitgetBitget · Tue, 11 Aug 2026 00:05:09 GMTAbCellera's hot flash antibody shows promise for once-monthly dosing - FirstWord PHARMAFirstWord PHARMA · Mon, 10 Aug 2026 22:07:20 GMTAbCellera Stock Soars 41% After Positive Hot-Flash Trial Data - Briefs FinanceBriefs Finance · Mon, 10 Aug 2026 22:03:09 GMTAbCellera (NASDAQ:ABCL) jumps 37.5% as hot-flash trial hits all main and secondary goals - TechStock²TechStock² · Mon, 10 Aug 2026 18:58:02 GMTMenopause drug cuts hot flashes in mid-stage trial, company says as shares rise - BNN BloombergBNN Bloomberg · Mon, 10 Aug 2026 14:25:51 GMTAbCellera stock soars on ‘off the chart’ trial results from hot flash treatment for menopausal women - The Globe and MailThe Globe and Mail · Mon, 10 Aug 2026 13:32:45 GMTIMPulse Trial Tests FLASH Radiotherapy for Melanoma Skin Metastases - OncodailyOncodaily · Sat, 01 Aug 2026 16:28:10 GMT